GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asymchem Laboratories Tianjin Co Ltd (HKSE:06821) » Definitions » Short Percentage of Float

Asymchem Laboratories Tianjin Co (HKSE:06821) Short Percentage of Float


View and export this data going back to 2021. Start your Free Trial

What is Asymchem Laboratories Tianjin Co Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of Asymchem Laboratories Tianjin Co's Short Percentage of Float

For the Biotechnology subindustry, Asymchem Laboratories Tianjin Co's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asymchem Laboratories Tianjin Co's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Asymchem Laboratories Tianjin Co's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Asymchem Laboratories Tianjin Co's Short Percentage of Float falls into.


;
;

Asymchem Laboratories Tianjin Co Business Description

Traded in Other Exchanges
Address
No. 6 Dongting Third Street, Economic and Technological Development Zone, Tianjin, CHN, 300457
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development manufacturing organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing which focuses on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
Executives
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Citigroup Inc. 2201 Interest of corporation controlled by you
Schroders Plc 2102 Investment manager
Norges Bank 2101 Beneficial owner
Fmr Llc 2201 Interest of corporation controlled by you
Fidelity Investment Trust 2101 Beneficial owner
Springhill Fund Asset Management (hk) Company Limited 2102 Investment manager
Springhill Fund Limited 2201 Interest of corporation controlled by you
Springhill Global Feeder Fund Limited 2201 Interest of corporation controlled by you
Springhill Master Fund Limited 2101 Beneficial owner
Morgan Stanley 2201 Interest of corporation controlled by you
Hhlr Advisors, Ltd. 2102 Investment manager
Hhlr Fund, L.p. 2101 Beneficial owner
Jpmorgan Asset Management (asia Pacific) Limited 2102 Investment manager
Fidelity Management & Research Company Llc

Asymchem Laboratories Tianjin Co Headlines

No Headlines